Tschodu D, Ulm B, Bendrat K, Lippoldt J, et al. Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature. PLoS One 2022;17:e0261035.
PMID: 35143511